Intelligence · Clinical Pipeline
Iovance Biotherapeutics Pipeline
All ClinicalTrials.gov programs at Iovance Biotherapeutics — phase, modality, and trial IDs.
- Programs
- 12
Quick answer
Iovance Biotherapeutics has 12 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Cyclophosphamide
Iovance Biotherapeutics B.V.
Locally Advanced Melanoma
1 trial -
IOV-2001
Iovance Biotherapeutics B.V.
Chronic Lymphocytic Leukemia
1 trial -
Interleukin-2
Iovance Biotherapeutics B.V.
Chronic Graft Versus Host Disease
1 trial -
KK-LC-1 TCR-T cells
Iovance Biotherapeutics B.V.
Gastric Cancer
1 trial -
LN-144
Iovance Biotherapeutics B.V.
Stage IIIB Melanoma
1 trial -
LN-145/LN-144
Iovance Biotherapeutics B.V.
Soft Tissue Sarcoma
1 trial -
Lifileucel (LN-144)
Iovance Biotherapeutics B.V.
Metastatic Melanoma
1 trial -
Lifileucel (LN-144/LN-145)
Iovance Biotherapeutics B.V.
Uveal Melanoma
1 trial -
Nivolumab
Iovance Biotherapeutics B.V.
Melanoma (Skin)
1 trial -
Nivolumab
Iovance Biotherapeutics B.V.
Non-Small Cell Lung Cancer
1 trial -
TIL
Iovance Biotherapeutics B.V.
Sarcoma
1 trial -
locally manufactured adoptive cellular therapy (ACT) product
Iovance Biotherapeutics B.V.
Malignant Pleural Effusion
1 trial
Frequently asked questions
How many pipeline programs does Iovance Biotherapeutics have?
12 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs